Abstract
This cross-sectional study compares the yield of glucose-6-phosphate dehydrogenase deficiency screening strategies between universal screening, mandated screening for at-risk newborns, and usual care.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureElizabeth R. Wolf, Colin J. Orr, Alex R. Kemper
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Glucose-6-phosphate dehydrogenase deficiency.
10.1182/blood.2019000944 · 2020
Combating the hidden health disparity of kernicterus in Black infants: a review.
10.1001/jamapediatrics.2020.1767 · 2020
Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.
10.1542/peds.2022-058859 · 2022
Pediatric provider insight into newborn screening for glucose-6-phosphate dehydrogenase deficiency.
10.1177/0009922814557786 · 2015
The Cosmos Collaborative: a vendor-facilitated electronic health record data aggregation platform.
10.1055/s-0041-1731004 · 2021
Implementation of universal screening for G6PD deficiency in newborns.
10.1542/peds.2024-065900 · 2024
Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States?
10.1038/jp.2013.14 · 2013
Unresolved referenced work
Kept as external metadata until matched
No additional external references are available.
europepmc
Confidence 96%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%